CVS, Walgreen Suspend OTC Ranitidine Sales As FDA Investigates Contamination

CVS, Walgreen suspend sales of brand and store brand ranitidine OTCs while Sanofi confirms it is not recalling Zantac in the US and has no plans to cease manufacturing or distributing.

CVS Storefront

More from Recalls

More from Policy & Regulation